Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Feb;87(2):725–728. doi: 10.1172/JCI115052

A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.

M Ito 1, Y Mori 1, Y Oiso 1, H Saito 1
PMCID: PMC296365  PMID: 1840604

Abstract

To elucidate the molecular mechanism of familial central diabetes insipidus (FDI), we sequenced the arginine vasopressin-neurophysin II (AVP-NPII) gene in 2 patients belonging to a pedigree that is consistent with an autosomal dominant mode of inheritance. 10 patients with idiopathic central diabetes insipidus (IDI) and 5 normals were also studied. The AVP-NPII gene, locating on chromosome 20, consists of three exons that encode putative signal peptide, AVP, NPII, and glycoprotein. Using polymerase chain reaction, fragments including the promoter region and all coding regions were amplified from genomic DNA and subjected to direct sequencing. Sequences of 10 patients with IDI were identical with those of normals, while in 2 patients with FDI, a single base substitution was detected in one of two alleles of the AVP-NPII gene, indicating they were heterozygotes for this mutation. It was a G----A transition at nucleotide position 1859 in the second exon, resulting in a substitution of Gly for Ser at amino acid position 57 in the NPII moiety. It was speculated that the mutated AVP-NPII precursor or the mutated NPII molecule, through their conformational changes, might be responsible for AVP deficiency.

Full text

PDF
725

Images in this article

727Image
on p.727
727Image
on p.727

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balaram P., Bothner-By A. A., Breslow E. Nuclear magnetic resonance studies of the interaction of peptides and hormones with bovine neurophysin. Biochemistry. 1973 Nov 6;12(23):4695–4704. doi: 10.1021/bi00747a024. [DOI] [PubMed] [Google Scholar]
  2. Baylis P. H., Robertson G. L. Vasopressin function in familial cranial diabetes insipidus. Postgrad Med J. 1981 Jan;57(663):36–40. doi: 10.1136/pgmj.57.663.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Breslow E. Chemistry and biology of the neurophysins. Annu Rev Biochem. 1979;48:251–274. doi: 10.1146/annurev.bi.48.070179.001343. [DOI] [PubMed] [Google Scholar]
  4. Breslow E., Pagnozzi M., Co R. T. Chemical modification or excision of neurophysin arginine-8 is associated with loss of peptide-binding ability. Biochem Biophys Res Commun. 1982 May 14;106(1):194–201. doi: 10.1016/0006-291x(82)92077-0. [DOI] [PubMed] [Google Scholar]
  5. Brownstein M. J., Russell J. T., Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science. 1980 Jan 25;207(4429):373–378. doi: 10.1126/science.6153132. [DOI] [PubMed] [Google Scholar]
  6. Burman S., Wellner D., Chait B., Chaudhary T., Breslow E. Complete assignment of neurophysin disulfides indicates pairing in two separate domains. Proc Natl Acad Sci U S A. 1989 Jan;86(2):429–433. doi: 10.1073/pnas.86.2.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fassina G., Chaiken I. M. Structural requirements of peptide hormone binding for peptide-potentiated self-association of bovine neurophysin II. J Biol Chem. 1988 Sep 25;263(27):13539–13543. [PubMed] [Google Scholar]
  8. Garnier J., Osguthorpe D. J., Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978 Mar 25;120(1):97–120. doi: 10.1016/0022-2836(78)90297-8. [DOI] [PubMed] [Google Scholar]
  9. Guldenaar S. E., Nahke P., Pickering B. T. Immunocytochemical evidence for the presence of a mutant vasopressin precursor in the supraoptic nucleus of the homozygous Brattleboro rat. Cell Tissue Res. 1986;244(2):431–436. doi: 10.1007/BF00219218. [DOI] [PubMed] [Google Scholar]
  10. Haltiner M., Kempe T., Tjian R. A novel strategy for constructing clustered point mutations. Nucleic Acids Res. 1985 Feb 11;13(3):1015–1025. doi: 10.1093/nar/13.3.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ito M., Tanimoto M., Kamura H., Yoneda M., Morishima Y., Yamauchi K., Itatsu T., Takatsuki K., Saito H. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1989 Jul;69(1):100–104. doi: 10.1210/jcem-69-1-100. [DOI] [PubMed] [Google Scholar]
  12. Kaplowitz P. B., D'Ercole A. J., Robertson G. L. Radioimmunoassay of vasopressin in familial cental diabetes insipidus. J Pediatr. 1982 Jan;100(1):76–81. doi: 10.1016/s0022-3476(82)80238-2. [DOI] [PubMed] [Google Scholar]
  13. Krisch B., Nahke P., Richter D. Immunocytochemical staining of supraoptic neurons from homozygous Brattleboro rats by use of antibodies against two domains of the mutated vasopressin precursor. Cell Tissue Res. 1986;244(2):351–358. doi: 10.1007/BF00219211. [DOI] [PubMed] [Google Scholar]
  14. Land H., Schütz G., Schmale H., Richter D. Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature. 1982 Jan 28;295(5847):299–303. doi: 10.1038/295299a0. [DOI] [PubMed] [Google Scholar]
  15. Moses A. M., Notman D. D. Diabetes insipidus and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Adv Intern Med. 1982;27:73–100. [PubMed] [Google Scholar]
  16. Peyton D., Sardana V., Breslow E. Dimerization of native and proteolytically modified neurophysins as monitored by proton magnetic resonance spectroscopy: proximity of tyrosine-49 to the subunit interface. Biochemistry. 1986 Oct 21;25(21):6579–6586. doi: 10.1021/bi00369a036. [DOI] [PubMed] [Google Scholar]
  17. Repaske D. R., Phillips J. A., 3rd, Kirby L. T., Tze W. J., D'Ercole A. J., Battey J. Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab. 1990 Mar;70(3):752–757. doi: 10.1210/jcem-70-3-752. [DOI] [PubMed] [Google Scholar]
  18. Rholam M., Nicolas P., Cohen P. Binding of neurohypophyseal peptides to neurophysin dimer promotes formation of compact and spherical complexes. Biochemistry. 1982 Sep 28;21(20):4968–4973. doi: 10.1021/bi00263a021. [DOI] [PubMed] [Google Scholar]
  19. Riddell D. C., Mallonee R., Phillips J. A., Parks J. S., Sexton L. A., Hamerton J. L. Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor. Somat Cell Mol Genet. 1985 Mar;11(2):189–195. doi: 10.1007/BF01534707. [DOI] [PubMed] [Google Scholar]
  20. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  21. Sardana V., Carlson J. D., Breslow E., Peyton D. Chemical modification and cross-linking of neurophysin tyrosine-49. Biochemistry. 1987 Feb 24;26(4):995–1003. doi: 10.1021/bi00378a004. [DOI] [PubMed] [Google Scholar]
  22. Sausville E., Carney D., Battey J. The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem. 1985 Aug 25;260(18):10236–10241. [PubMed] [Google Scholar]
  23. Scherbaum W. A., Bottazzo G. F. Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant. Lancet. 1983 Apr 23;1(8330):897–901. doi: 10.1016/s0140-6736(83)91328-4. [DOI] [PubMed] [Google Scholar]
  24. Schmale H., Heinsohn S., Richter D. Structural organization of the rat gene for the arginine vasopressin-neurophysin precursor. EMBO J. 1983;2(5):763–767. doi: 10.1002/j.1460-2075.1983.tb01497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schmale H., Richter D. Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature. 1984 Apr 19;308(5961):705–709. doi: 10.1038/308705a0. [DOI] [PubMed] [Google Scholar]
  26. Winship P. R. An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res. 1989 Feb 11;17(3):1266–1266. doi: 10.1093/nar/17.3.1266. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES